Inspire Medical Systems Future Growth
Future criteria checks 4/6
Inspire Medical Systems is forecast to grow earnings and revenue by 51.9% and 17.5% per annum respectively. EPS is expected to grow by 52.7% per annum. Return on equity is forecast to be 6.3% in 3 years.
Key information
51.9%
Earnings growth rate
52.7%
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 17.5% |
| Future return on equity | 6.3% |
| Analyst coverage | Good |
| Last updated | 24 Apr 2024 |
Recent future growth updates
Recent updates
Inspire Medical Systems: A Potential Example Of Market Mispricing
Apr 05Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate
Mar 27
Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?
Mar 06Inspire Medical: A Good Night Sleep
Feb 08Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors
Dec 26Inspire Medical Systems: Time To Wake Up
Nov 17An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued
Nov 13Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth
Oct 25When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?
Sep 05Inspire Medical Systems: Excellent Execution And Reset Valuation
Aug 17Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?
Aug 10Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment
Jul 19Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing
Jul 16Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating
Jun 15Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching
May 06Inspire Medical stock rises after guiding revenue above estimates
Jan 09Inspire Medical nears eight-month high as KeyBanc issues bullish call
Dec 13Inspire Medical Systems: Sleep Apnea Equipment - Today's Best Stock Buy
Oct 26Inspire Medical Systems: Sleep Apnea Value Delivery Pocket
Oct 13Inspire Medical Systems prices 1M of stock offering at $215.00/share
Aug 12Inspire Medical Systems GAAP EPS of -$0.53 beats by $0.07, revenue of $91.4M beats by $13.34M
Aug 02Inspire Medical gets FDA nod for full-body MRI compatibility with Inspire therapy
Jul 06Inspire Medical Systems Priced Low In Past-Year Repeated Range
May 12Inspire Medical Systems (NYSE:INSP) Has Debt But No Earnings; Should You Worry?
May 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,142 | 67 | 124 | 151 | 12 |
| 12/31/2025 | 950 | 24 | 86 | 94 | 18 |
| 12/31/2024 | 782 | -9 | 61 | 65 | 18 |
| 12/31/2023 | 625 | -21 | 1 | 25 | N/A |
| 9/30/2023 | 570 | -33 | 8 | 27 | N/A |
| 6/30/2023 | 526 | -41 | 19 | 34 | N/A |
| 3/31/2023 | 466 | -44 | 11 | 23 | N/A |
| 12/31/2022 | 408 | -45 | 2 | 12 | N/A |
| 9/30/2022 | 348 | -50 | -14 | -7 | N/A |
| 6/30/2022 | 301 | -44 | -23 | -18 | N/A |
| 3/31/2022 | 262 | -43 | -27 | -22 | N/A |
| 12/31/2021 | 233 | -42 | -25 | -20 | N/A |
| 9/30/2021 | 201 | -47 | -30 | -25 | N/A |
| 6/30/2021 | 175 | -47 | -38 | -34 | N/A |
| 3/31/2021 | 134 | -57 | -52 | -49 | N/A |
| 12/31/2020 | 115 | -57 | -55 | -53 | N/A |
| 9/30/2020 | 96 | -59 | -57 | -55 | N/A |
| 6/30/2020 | 81 | -57 | -51 | -49 | N/A |
| 3/31/2020 | 87 | -41 | -39 | -37 | N/A |
| 12/31/2019 | 82 | -33 | -36 | -33 | N/A |
| 9/30/2019 | 72 | -29 | -32 | -29 | N/A |
| 6/30/2019 | 64 | -25 | -31 | -30 | N/A |
| 3/31/2019 | 57 | -24 | -24 | -23 | N/A |
| 12/31/2018 | 51 | -22 | -19 | -19 | N/A |
| 9/30/2018 | 44 | -21 | -20 | -19 | N/A |
| 6/30/2018 | 38 | -21 | -19 | -19 | N/A |
| 3/31/2018 | 33 | -20 | -17 | -17 | N/A |
| 12/31/2017 | 29 | -18 | -16 | -16 | N/A |
| 12/31/2016 | 16 | -19 | N/A | -18 | N/A |
| 12/31/2015 | 8 | -21 | N/A | -22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: INSP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: INSP is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: INSP is expected to become profitable in the next 3 years.
Revenue vs Market: INSP's revenue (17.5% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: INSP's revenue (17.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: INSP's Return on Equity is forecast to be low in 3 years time (6.3%).